Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Associate Professor Jonathan Cook has been elected to the Society for Clinical Trials (SCT) board.

Jonathan Cook

The SCT is an international organisation that advocate for the use of clinical trials to inform science and advance human health and wellness. For more than four decades they have been a forum for the development and dissemination of optimal methods and practises in clinical trials.

Associate Professor Jonathan Cook joined the Centre for Statistics in Medicine at NDORMS in 2013. He is an experienced statistician, and Deputy Director of the Oxford Clinical Trials Research Unit (OCTRU). He oversees the statistical input into clinical trials and undertakes related methodological research.

On being elected to the SCT board, Jonathan said “I was surprised but grateful to be elected to the SCT Board of Directors. Attending and presenting at the SCT annual meeting has always been a highlight of my year. I’m looking forward to contributing to the Society’s work and serving the membership and friends of SCT. The vital contribution of clinical trials to modern medicine has perhaps never been more prominent in the public sphere than it is today. The SCT has an important role to play in advocating for clinical trials, stimulating methodological development, and encouraging best practice”.

Similar stories

Study uncovers how cancer stem cells spread and resist treatment

NDORMS researchers have identified a critical axis that controls the formation and behaviour of cancer stem cells (CSCs), a subpopulation of cells that influence how lethal the cancer can be, its resistance to chemotherapy, and its ability to spread to other parts of the body.